Navigation Links
Exclusive agreement to distribute Affinity Biosensors' Archimedes system extends Malvern Instruments' biopharma solutions
Date:10/29/2012

ential regulation. Archimedes will sit alongside Malvern's Zetasizer and Viscotek systems, all of which deliver complementary solutions for customers in this fast growing pharmaceutical industry sector."

Affinity Biosensors' CEO Ken Babcock commented, "Archimedes has been adopted at many leading US biopharmaceutical companies. Our partnership with Malvern will extend Archimedes' reach worldwide, and we are glad to see it alongside Malvern's leading materials characterization technology. Archimedes users are sure to benefit from Malvern's world-class support and applications expertise."

Archimedes allows precise measurement of size and mass of particles with diameters down to 50nm. Measurements are unaffected by optical or shape variations, and gentle fluidics ensure that fragile aggregates are not disrupted. The instrument can measure high viscosity samples and consumes as little as 100µl of precious protein formulation.  Archimedes can accept particle concentrations up to 1x109 per ml, allowing direct study of undiluted high concentration formulations.

Archimedes can also differentiate between protein aggregates and silicone oil droplets in an injectable biopharmaceutical using buoyant mass measurement, something that no other technology can do at the submicron size scale.

Details of Malvern's rapidly expanding range of protein characterization solutions are available at www.malvern.com/protein-aggregation, with full descriptions and specifications for the new Archimedes systems at www.malvern.com/archimedes

Malvern and Malvern Instruments are registered trademarks of Malvern Instruments Ltd

About Malvern Instruments

Malvern Instruments is a market leader in measuring performance-controlling material properties. These include particle size, particle shape, zeta potential, mole
'/>"/>

SOURCE Affinity Biosensors
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. "Babolat Play & Connect" - Worldwide Exclusive Event at the French Open
2. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
3. NJIT, Chinas Bengbu Glass Institute sign agreement for R&D, training
4. BGI, GMU, Mass. Eye and Ear and OUHSC announce agreement to sequence 100 human adenoviruses
5. Springer and the Beijing Normal University Press sign agreement on new book series
6. Premier Healthcare Renews Supplier Agreement with Masimo
7. Saladax Biomedical Enters into Master Collaboration Agreement with Bristol-Myers Squibb
8. BP Biofuels, Texas AgriLife Research sign agreement to advance biofuel feedstock development
9. Wiley signs collaboration agreement with the Asian Federation of Biotechnology
10. IU biologists offer clearer picture of how protein machine systems tweak gene expression
11. Unexpected crustacean diversity discovered in northern freshwater ecosystems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... has been discovered by a research group at the Sahlgrenska ... an insidious form of glandular cancer usually in the head ... discovery could lead to quicker and better diagnosis and more ... prestigious scientific journal Proceedings of the National Academy of ...
... animals and plants developed different genetic programs for cell ... one at the Swedish University of Agricultural Sciences, has ... programmed cell death in plants and animals are actually ... The findings were published in Nature Cell Biology ...
... in electronics applications, Kansas State University engineers made a ... Berry is a K-State assistant professor of chemical engineering ... single atom thick and discovered just five years ago. ... electronics properties -- Berry and Kabeer Jasuja, a K-State ...
Cached Biology News:New cancer gene discovered 2Cell death occurs in the same way in plants, animals and humans 224-carat gold 'snowflakes' improve graphene's electrical properties 2
(Date:3/2/2015)... 2, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, today announced that it will release fourth ... on Tuesday, March 10, 2015 after the close of ... conference call and webcast on Tuesday, March 10, 2015 ... discuss the results and recent corporate developments. ...
(Date:3/2/2015)... 02, 2015 Global Stem ... alliance with Shenzhen HANK Bioengineering Co., Ltd. and ... alliance will establish a stem cells training course ... in September 2015. , Shenzhen HANK is a ... award-winning scientist, microbiologist and virologist, to integrate research, ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO Controversy ... of The GMO TRUTH podcast on both ITunes and at ... its mission to discover the truth and change the world. ... the truth about the GMOs in our food supply,” adds ... is an expansion of the documentary/investigative film-making methodology in place ...
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... toxicology studies for its newly developed Bruton,s tyrosine ... have been completed. The results of these preclinical ... and Drug Administration. The feedback received from the ... ongoing first-in-human study. Additional preclinical work is required ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... March 31, 2009. Vanda reported a net loss ... compared to $7.5 million for the fourth quarter of ...
... Mass., April 29 LaVoie Group, a life ... has been selected as public relations agency of ... Inc. Donna L. LaVoie, President & CEO of ... Profectus during an important stage in the company,s ...
... billions in pest losses annually , ... St. Louis, MO (PRWEB) April ... Divergence, Inc. , has received more than $1.2 million in research grants, ... to further the company,s work on biotech traits for lesion nematode control ...
Cached Biology Technology:Vanda Pharmaceuticals Reports First Quarter 2009 Results 2Vanda Pharmaceuticals Reports First Quarter 2009 Results 3Vanda Pharmaceuticals Reports First Quarter 2009 Results 4Vanda Pharmaceuticals Reports First Quarter 2009 Results 5Vanda Pharmaceuticals Reports First Quarter 2009 Results 6Vanda Pharmaceuticals Reports First Quarter 2009 Results 7Vanda Pharmaceuticals Reports First Quarter 2009 Results 8Vanda Pharmaceuticals Reports First Quarter 2009 Results 9Vanda Pharmaceuticals Reports First Quarter 2009 Results 10LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 2Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn 3
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-Gemin2...
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Biology Products: